Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MDR-TB”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT05381194
What this trial is testing

BPaL(M) Regimen for the Treatment of MDR/RR-TB

Who this might be right for
Multidrug- and Rifampicin-resistant Tuberculosis
Asan Medical Center 80
Large-scale testing (Phase 3)Ended earlyNCT01055145
What this trial is testing

Comparison of the Effect Between Levofloxacin and Moxifloxacin Among MDR-TB Patients

Who this might be right for
TB
Seoul National University Hospital 182
Not applicableStudy completedNCT03303963
What this trial is testing

DIAgnostics for Multidrug Resistant Tuberculosis in Africa

Who this might be right for
Tuberculosis, Multidrug-Resistant
Dissou AFFOLABI 3,356
Not applicableUnknownNCT02245347
What this trial is testing

Genome Sequencing of Multidrug Resistant Tuberculosis (MDR TB) in Sputum

Who this might be right for
Tuberculosis
St George's Healthcare NHS Trust 50
Post-approval studies (Phase 4)Looking for participantsNCT07477119
What this trial is testing

Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment

Who this might be right for
LinezolidTuberculosis Multi Drug Resistant ActiveTherapeutic Drug Monitoring (TDM)
Marco Schiuma 150
Post-approval studies (Phase 4)Looking for participantsNCT05493267
What this trial is testing

A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB

Who this might be right for
MDR-TBImmunotherapy
Shanghai Pulmonary Hospital, Shanghai, China 30
Large-scale testing (Phase 3)Study completedNCT02409290
What this trial is testing

The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB

Who this might be right for
MDR-TB
IUATLD, Inc 588
Not applicableStudy completedNCT03137875
What this trial is testing

Evaluation of PCR Using DNA Extract From Slides and Filter Paper for the Detection of Tuberculosis and MDR-tuberculosis

Who this might be right for
TuberculosisMulti Drug Resistant Tuberculosis
Epicentre 122
Not applicableStudy completedNCT07003581
What this trial is testing

Cardiometabolic Risk Factors Associated With Multidrug-Resistant Tuberculosis

Who this might be right for
Tuberculosis (TB)
B.P. Koirala Institute of Health Sciences 183
Not applicableUnknownNCT02496572
What this trial is testing

Effectiveness of a Simplified Short Regimen for Multidrug Resistant Tuberculosis in Uzbekistan

Who this might be right for
Multidrug Resistant Tuberculosis
Medecins Sans Frontieres, Netherlands 110
Large-scale testing (Phase 3)Looking for participantsNCT07486024
What this trial is testing

Feasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Patients in France (FAST-MDR)

Who this might be right for
MDR-TBTuberculosis Multi Drug Resistant ActiveAntibiotic Resistance+1 more
Assistance Publique - Hôpitaux de Paris 55
Large-scale testing (Phase 3)Study completedNCT00513396
What this trial is testing

High-Dose Isoniazid Adjuvant Therapy for Multidrug Resistant Tuberculosis

Who this might be right for
Tuberculosis, Multidrug-Resistant
GSVM Medical College 134
Not applicableNot Yet RecruitingNCT06700577
What this trial is testing

Multidrug Resistance in Newly Diagnosed TB Patient

Who this might be right for
Tuberculosis
Assiut University 100
Early research (Phase 1)Study completedNCT04309656
What this trial is testing

Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid

Who this might be right for
Multi-drug Resistant Tuberculosis
Global Alliance for TB Drug Development 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07393438
What this trial is testing

Acetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS)

Who this might be right for
Multidrug-Resistant TuberculosisRifampicin-resistant TuberculosisMDR-TB+1 more
Shanghai Pulmonary Hospital, Shanghai, China 120
Not applicableStudy completedNCT02169141
What this trial is testing

Pharmacokinetics of Levofloxacin and Capreomycin in Multidrug-Resistant Tuberculosis Patients

Who this might be right for
Tuberculosis
University Medical Center Groningen 20
Large-scale testing (Phase 3)Study completedNCT02607449
What this trial is testing

FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis

Who this might be right for
Tuberculosis, MDR
Scientific Center for Anti-infectious Drugs, Kazakhstan 344
Not applicableUnknownNCT00676754
What this trial is testing

Epidemiology of MDR-TB in Peru

Who this might be right for
TB Multi-drug Resistant
Harvard University Faculty of Medicine 18,544
Large-scale testing (Phase 3)WithdrawnNCT02975570
What this trial is testing

Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin

Who this might be right for
Tuberculosis Multi Drug Resistant Active
Boston University
Not applicableUnknownNCT04397536
What this trial is testing

New Genomic Techniques and Management of Multidrug-resistant Tuberculosis

Who this might be right for
Multi-Drug Resistant Tuberculosis
Assistance Publique - Hôpitaux de Paris 172
Next Page